U.S., Oct. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07215260) titled 'A Study in Healthy People to Test Whether BI 3000202 Affects How 2 Other Medicines (Rosuvastatin and Digoxin) Are Taken up in the Body' on Oct. 09.
Brief Summary: The objective of this trial is to assess the effect of BI 3000202 on the pharmacokinetics of rosuvastatin and digoxin given as a cocktail.
Study Start Date: Nov. 04
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DRUG: BI 3000202
BI 3000202
DRUG: Rosuvastatin
Rosuvastatin
DRUG: Digoxin
Digoxin
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Boehringer Ingelheim
Disclaimer: Curated by HT Syndication....